|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | A randomized, doubleblind, placebo controlled phase II study of vandetanib plus docetaxel/prednisolone in patients with hormone refractory prostate cancer显示文摘 | Horti J Widmark A Stenzl A | 2009 | Cancer Biother Radiopharm2009，24，2： | 1 |
| 2 | A randomized, double-blind, placebo-controlled phase II study of vandetanih plus docetaxel/prednisolone in patients with hormone-refractory prostate cancer 显示文摘 | HORTI J WIDMARK A STENZL A | 2009 | Cancer Biother Radiopharm2009，24，2： | 1 |
| 3 | Coexistence of a lung carcinosarcoma and hydatid cyst 显示文摘 | Misthos P Kanakis MA Horti M | 2013 | Updates Surg2013，65，3： | 1 |
| 4 | Docetaxel plus prednisone or mitoxantrone plus predni- sone for advanced prostate caneer显示文摘 | Tannock I F de Wit R Berry W R Horti J Pluzanska A Chi K N | 2004 | N Engl J Med2004，351，： | 1 |
| 5 | A randomised dou- bleblind placebo-controlled phase Ⅱ study of vandetanib plus do- cetaxel/prednisolone in patients with hormone refractory prostate cancer显示文摘 | HORTI J WIDMARK A STENZL A | 2009 | Cancer Biother Radiopharm2009，24，2： | 1 |
| 6 | The quest for Eldorado:development of radioligands for in vivo imaging of nicotinic acetylcholine receptors in human brain显示文摘 | Horti AG Villemagne VL | 2006 | Curr Pharm Des2006，12，30： | 1 |
| 7 | Clinical perspective and recent development of PET radioligands for imaging cerebral nicotinic acetylcholine receptors显示文摘 | Horti AG Wong DF | | 0，，： | 1 |
| 8 | Phase I Study of TZT-1027,aNovel Synthetic Dolastatin 10 Derivative, for theTreatment of Patients with Non-small Cell Lung Canc-er显示文摘 | HORTI J’JUHASZ E | 2008 | Cancer Chemother Pharmacol2008，，62： | 1 |
| 9 | Development of radioligands with optimized imaging properties for quantification of nicotinic acetylcholine receptors by positron emission tomography显示文摘 | Horti AG Gao Y Kuwabara H | | 0，，： | 1 |
| 10 | Inflation, minimum wage and other wages : an econometric study on French macroeconomic data 显示文摘 | Yannick L' Horty Christophe Rault | 2004 | Applied Economics2004，，36： | 1 |
| 11 | Enhanced activity of estramustine, vinblastine, etoposide, and suramin in prostate carcinoma 显示文摘 | Arah IN Dixon SC Horti J | 1999 | Neoplasma1999，46，2： | 1 |
| 12 | Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer显示文摘 | Tannock IF de Wit R Berry WR Horti J Pluzanska A Chi KN Oudard S Theodore C James ND Turesson I Rosenthal MA Eisenberger MA TAX 327 Investigators | 2004 | N Engl J Med2004，351，15： | 1 |
| 13 | Phase I study of TZT-1027, a novel synthetic dolastatin 10 derivative, for the treatment of pa- tients with non-small cell lung cancer 显示文摘 | Horti J Juhasz E Monostori Z | 2008 | Cancer Chemother Pharmacol2008，62，1： | 1 |
| 14 | 6 - fluoro - A - 85380, a novel radioligand for in vivo imaging of central nicotine acetylcholine receptors 显示文摘 | Horti AG Chefer SI Mukhin AG | 2000 | Life Sci2000，67，4： | 1 |
| 15 | Prostate cancer screening 显示文摘 | Tenke P Horti J Balint P | 2007 | Recent Results Cancer Res2007，175，： | 1 |
| 16 | Phase I study of TZT-1027, a novel synthetic dolastatin 10 derivative, for the treatment of patients with non-small cell lung cancer显示文摘 | J. Horti E. Juhasz Z. Monostori K. Maeda S. Eckhardt I. Bodrogi | | 0，，： | 1 |
| 17 | Methods for extracting and amplifying genomic DNA isolated from frozen serum显示文摘 | Dixon SC Horti J Guo Y | 1998 | Nat Biotechnyuanol1998，16，： | 1 |
| 18 | Enhanced activity of estramustine,vinblastine,etoposide,and suramin in prostate carcinoma显示文摘 | Arah IN Dixon SC Horti J | 1999 | Neoplasma1999，46，2： | 1 |
| 19 | 2-FA-85380: a PET radioligand for 4 2 nicotinic aeetyleholine receptors 显示文摘 | Chefer SI Horti AG Koren AO | 1999 | Neuroreport1999，10，13： | 1 |
| 20 | An appreciation of John Pollock's work on the computational study of argument 显示文摘 | Henry Prakken John Horty | 2012 | Argument and Computation2012，3，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员